MR Imaging of the Prostate: 1.5T versus 3T

Magnetic Resonance Imaging Clinics of North America

Volumn 15, Issue 3, 2007, Pages 433-448

  Cornfeld, Daniel M ^a   Weinreb, Jeffrey C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE PROCESSING; IMAGE QUALITY; IMAGING SYSTEM; LYMPHOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATIENT POSITIONING; PROSTATE CANCER; REVIEW;

CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE ENHANCEMENT; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROSTATIC NEOPLASMS;

EID: 34548781844     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mric.2007.06.004     Document Type: Review

References (81)

1. American Cancer Society. Cancer facts and figures 2007. Publication no. 500807 (2006), American Cancer Society, Atlanta (GA)
2. Hricak H., Williams R.D., Spring D.B., et al. Anatomy and pathology of the male pelvis by magnetic resonance imaging. AJR Am J Roentgenol 141 6 (1983) 1101-1110
3. Hricak H., and Williams R.D. Magnetic resonance imaging and its application in urology. Urology 23 5 (1984) 442-454
4. Buonocore E., Hesemann C., Pavlicek W., et al. Clinical and in vitro magnetic resonance imaging of prostatic carcinoma. AJR Am J Roentgenol 143 6 (1984) 1267-1272
5. Wang L., Mullerad M., Chen H., et al. Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension. Radiology 232 (2004) 133-139
6. D'Amico A., Whittington R., Malkowicz B., et al. Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer. J Urol 164 3 Pt 1 (2000) 759-763
7. Yu K., Hricak H., Alagappan R., et al. Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology 202 (1997) 697-702
8. Yu K., Scheidler J., Hricak H., et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 213 (1999) 481-488
9. Zhang J., Dave A., Ricketts J., et al. Endorectal MR imaging and proton spectroscopy for preoperative evaluation of clinical T1c prostate cancer. Proceedings of the International Society of Magnetic Resonance in Medicine 15 (2007) 801
10. Hricak H., Wang L., Wei D., et al. The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy. Cancer 100 21 (2004) 2655-2663
11. Futterer J., Engelbrecht M., Huisman H., et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 237 (2005) 541-549
12. Scheidler J., Hricak H., Vigneron S., et al. Prostate cancer: localization with three dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology 213 (1999) 473-480
13. Futterer J., Heijmink S., Scheenen T., et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241 (2006) 449-458
14. Reinsberg S., Payne G., Riches S., et al. Combined use of diffusion-weighted MRI and H MR spectroscopy to increase accuracy in prostate cancer detection. AJR Am J Roentgenol 188 (2007) 91-98
15. Clarke D., Banks S., Wiederhorn R., et al. The role of endorectal coil MRI in patient selection and treatment planning for prostate seed implants. Int J Radiat Oncol Biol Phys 52 4 (2002) 903-910
16. Mullerad M., Hricak H., Kuriowa K., et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 174 (2005) 2158-2163
17. Wefer A., Hricak H., Vigneron D., et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopy imaging with step section histology. J Urol 164 (2000) 400-404
18. Costouros N., Coakley F., Westphalen A., et al. Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging. Am J Roentgenol 188 (2007) 812-816
19. Ansellem-Ouazana S., Younes P., Conquy S., et al. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging a useful tool? A preliminary study. Eur Urol 47 (2005) 582-586
20. Taouli B., Chin D., Stifelman M., et al. Role of 3D 1H MR spectroscopy for prospective detection of prostate cancer in men with prior negative biopsies. Proceedings of the International Society of Magnetic Resonance in Medicine 15 (2007) 3670
21. Akin O., Sala E., Moskowitz C., et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 239 (2006) 784-792
22. Li H., Sugimura K., Kaji Y., et al. Conventional MRI capabilities in the diagnosis of prostate cancer in the transition zone. AJR Am J Roentgenol 186 (2006) 729-742
23. Zakian K., Eberhardt S., Hricak H., et al. Transition zone prostate cancer: metabolic characteristics at H MR spectroscopic imaging-initial results. Radiology 229 (2003) 241-247
24. Sala E., Eberhardt S., Akin O., et al. Endorectal MR imaging before salvage prostatectomy: tumor localization and staging. Radiology 238 (2006) 176-183
25. Coakley F., Teh H., Quayyum A., et al. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology 233 (2004) 441-448
26. Pucar D., Shukla-Dave A., Hricak H., et al. Prostate cancer: correlation of MRI imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. Radiology 236 (2005) 545-553
27. Hricak H., White S., Vigneron D., et al. Carcinoma of the prostate gland with pelvic phased array coils versus integrated endorectal-pelvic phased array-coils. Radiology 193 (1994) 703-709
28. Engelbrecht M., Jager G., Laheij R., et al. Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 12 9 (2002) 2294-2302
29. Torricelli P., Cinquantini F., Ligabue G., et al. Comparative evaluation between external phased array coil at 3T and endorectal coil at 1.5T. J Comput Assist Tomogr 30 3 (2006) 355-361
30. Sosna J., Pedrosa I., DeWolf W., et al. MR imaging of the prostate at 3 tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 tesla. Acad Radiol 11 (2004) 857-862
31. Beyersdorff D., Taymoorian K., Knosel T., et al. MRI of prostate cancer at 1.5 and 3T: comparison of image quality in tumor detection and staging. AJR Am J Roentgenol 185 (2005) 1214-1220
32. Heijmink S., Futterer J., Takahashi S., et al. A comparison of image quality and prostate cancer localization and staging performance between body array coil and endorectal coil MR imaging at 3T. Proceedings of the International Society of Magnetic Resonance in Medicine 14 (2006) 170
33. Futterer J., Scheenen T., Huisman H., et al. Initial experience of 3 tesla endorectal coil magnetic resonance imaging and H-spectroscopic imaging of the prostate. Invest Yadiol 39 (2004) 671-680
34. Heijmink S., Futterer J., Hambrock T., et al. Prostate cancer: body-array versus endorectal coil MR imaging at 3T-comparison of image quality, localization, and staging performance. Radiology 244 (2007) 184-195
35. Rosen Y., Bloch B., Lenkinski R., et al. 3T MR of the prostate: reducing susceptibility gradients by inflating the endorectal coil with a barium sulfate suspension. Magn Reson Med 57 (2007) 898-904
36. Choi H, Ma J. Use of perfluorocarbon (PFC) in magnetic resonance spectroscopy (MRS) of the prostate: a method to improve the linewidth and quality of the spectra. Proceedings of the 90th Annual Meeting of RSNA, Chicago, November 28-December 3, 2004. p. 270.
37. Prando A., Kurhanewicz J., Borges A., et al. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology 236 (2005) 903-910
38. Hamilton G., Middelton M., Choi S., et al. Improved MR spectral analysis for a PFC-filled endo-rectal prostate surface coil compared to an air-filled coil. Proceedings of the International Society of Magnetic Resonance in Medicine 15 (2007) 1400
39. Bloch B., Rofsky N., Baroni R., et al. 3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils: initial experience. Acad Radiol 11 (2004) 863-867
40. Chen A., Xu D., Sotto C., et al. High resolution MRSI and DTI of prostate cancer at 3T. Proceedings of the International Society of Magnetic Resonance in Medicine 15 (2007) 2887
41. Schricker A., Pauly J., Kurhanewicz J., et al. Dualband spectral-spatial RF pulses for prostate MR spectroscopic imaging. Magn Reson Med 46 (2001) 1079-1089
42. Le Roux P., Gilles R., McKinnon G., et al. Optimized outer volume suppression for single-shot fast spin-echo cardiac imaging. J Magn Reson Imaging 8 (1998) 1022-1032
43. Tran T., Vigneron D., Sailasuta N., et al. Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. Magn Reson Med 43 (2000) 23-33
44. Chen A., Cunningham C., Xu D., et al. 3 Tesla high resolution 3D MR spectroscopic imaging of the prostate with a MLEV-PRESS sequence. Proceedings of the International Society of Magnetic Resonance in Medicine 13 (2005) 261
45. Kim D, Margolis S, Daniel B, et al. Magnetic resonance spectroscopic imaging of the human prostate using spiral based J-resolved technique at 3 tesla main magnetic field. Proceedings of the 90th Annual Meeting of RSNA, Chicago, November 28-December 3, 2004.
46. Kaji Y, Kuroda K, Matsuoka Y, et al. Rigorous shimming in Prostate CSI Study at 3T. Proceedings of the 90th Annual Meeting of RSNA, Chicago, November 28-December 3, 2004.
47. Lange T., Trabesinger A., Schulte R., et al. Prostate spectroscopy at 3 tesla using two dimensional S-Press. Magn Reson Med 56 (2006) 1220-1228
48. Klomp D., Scheenen T., Hambrock T., et al. A new method for optimum MRSI of prostate at 3T using adiabatic RF pulses and internal water referencing. Proceedings of the International Society of Magnetic Resonance in Medicine 15 (2007) 2885
49. Schuster C., Scheenen T., Dreher W., et al. Fast 3D proton MR spectroscopic imaging of the human prostate in vivo at 3 tesla using "spectroscopic missing pulse-SSFP". Proceedings of the International Society of Magnetic Resonance in Medicine 15 (2007) 1243
50. Yasushi K., Kuroda K., Maeda T., et al. Anatomical and metabolic assessment of prostate using a 3-tesla MR scanner with a custom-made external transceive coil: Healthy Volunteer Study. J Magn Reson Imaging 25 (2007) 517-526
51. Scheenen T, Roell S, Heijmink S, et al. 3D H-MR spectroscopic imaging of the human prostate at 3T without an endorectal coil: a step towards MR screening of prostate cancer. Proceedings of the 91st Annual Meeting of RSNA, Chicago, November 27-December 2, 2005.
52. Guer O, Traeber F, Morakkabati-Spitz N, et al. 1H-MR spectroscopy of the prostate using a phase-array surface coil at 3T. Proceedings of the 92nd Annual Meeting of RSNA, Chicago, November 26-December 1, 2006.
53. Mancino S, Squillaci E, Manenti G, et al. Dynamic contrast-enhanced MRI and MR spectroscopy at 3 tesla of prostate cancer with pelvic phased array coil. Proceedings of the 92nd Annual Meeting of RSNA, Chicago, November 26-December 1, 2006.
54. Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging 16 (2002) 196-200
55. Gibbs P., Toser D., Liney G., et al. Comparison of qualitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate. Magn Reson Med 46 (2001) 1054-1058
56. Hosseinzadeh K., and Schwartz S. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging 20 (2004) 645-661
57. Tanimoto A., Nakashima J., Shinoda K., et al. The clinical value of ADC maps in the detection of prostate cancer. Proceedings of the International Society of Magnetic Resonance in Medicine 15 (2007) 3661
58. Haider M., van der Kwast T., Tanguay J., et al. Combined T2 and diffusion weighted MRI for localization of prostate cancer. Proceedings of the International Society of Magnetic Resonance in Medicine 15 (2007) 3663
59. Chen Y., Pu Y., Liang P., et al. Prostate cancer detection in patients with intermediate prostate specific antigen levels using high resolution diffusion tensor imaging prior to transrectal ultrasound guided biopsy. Proceedings of the International Society of Magnetic Resonance in Medicine 15 (2007) 3658
60. deSouza N., Riches S., vanAs N., et al. Potential value of diffusion weighted imaging as an indicator of tumor aggressiveness in prostate cancer. Proceedings of the International Society of Magnetic Resonance in Medicine 15 (2007) 3659
61. Yoshizako T., Uchida N., Wada A., et al. The ADC value in hormone refractory prostate cancers on diffusion-weighted MR images for predicting effect of chemotherapy. Proceedings of the International Society of Magnetic Resonance in Medicine 15 (2007) 3662
62. Pickles M., Gibbs P., Sreenivas M., et al. Diffusion-weighted imaging of normal and malignant prostate tissue at 3T. J Magn Reson Imaging 23 (2006) 130-134
63. Miao H., Fukatsu H., and Ishigaki T. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. Proceedings of the International Society of Magnetic Resonance in Medicine 61 (2007) 297-302
64. Bourne R., Stanwell P., Ramadan S., et al. ADC of prostate tissue in vivo at 3T. Proceedings of the International Society of Magnetic Resonance in Medicine 14 (2006) 2248
65. Gibbs P., Pickles D., Sreenivas M., et al. Repeatability of diffusion imaging of the prostate at 3T. Proceedings of the International Society of Magnetic Resonance in Medicine 13 (2005) 268
66. Namiki T, Koyama K, Tanaka H, et al. Effect of diffusion-weighted imaging with very high b-factors (2000, 3000) for detection of prostate cancer. Proceedings of the 91st Annual Meeting of RSNA, Chicago, November 27-December 2, 2005.
67. Sano M, Ichikaa T, Tsukamoto T, et al. Detection of prostatic cancer: usefulness of high b-value diffusion-weighted MR imaging. Proceedings of the 91st Annual Meeting of RSNA, Chicago, November 27-December 2, 2005.
68. Huisman H., Engelbrecht M., and Barentsz J. Accurate estimation of pharmacokinetic contrast-enhanced dynamic MRI parameters of the prostate. J Magn Reson Imaging 13 (2001) 607-614
69. Moate P., Dougherty L., Schnall M., et al. A modified logistic model to describe gadolinium kinetics in breast tumors. Magn Reson Imaging 22 (2004) 467-473
70. Tofts P. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 7 (1997) 91-101
71. Tofts P., Brix G., Buckley D., et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusible tracer: standardized quantities and symbols. J Magn Reson Imaging 10 (1999) 223-232
72. Englebrecht M., Huisman H., Laheij R., et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 229 (2003) 248-254
73. d'Arcy J., Collins D., Padhani A., et al. Informatics in radiology (infoRAD): magnetic resonance imaging workbench: analysis and visualization of dynamic contrast-enhanced MR imaging data. Radiographics 26 (2006) 621-632
74. Kim C., Park B., and Kim B. Localization of prostate cancer using 3T MRI: comparison of T2 weighted and dynamic contrast enhanced imaging. J Comput Assist Tomogr 30 1 (2006) 7-11
75. Gariib A., Jung E., Tomasson D., et al. T2 and dynamic contrast enhanced MR (DEC-MRI) imaging of prostate cancer at 3T. Proceedings of the International Society of Magnetic Resonance in Medicine 13 (2005) 2121
76. Lowry M., and Turnbull L. Analysis of prostate DCE-MRI at 3T using a measured arterial input function. Proceedings of the International Society of Magnetic Resonance in Medicine 14 (2006) 110
77. Eyal E., Block B., Furman-Haran E., et al. Pattern and model based analysis of dynamic contrast enhanced prostate MRI data. Proceedings of the International Society of Magnetic Resonance in Medicine 15 (2007) 523
78. Yu J., Chung J., Kim J., et al. Prostate cancer: added value of subtraction dynamic imaging in 3T magnetic resonance imaging with a phased-array body coil. Proceedings of the International Society of Magnetic Resonance in Medicine 15 (2007) 2886
79. * mapping versus T2-weighted MR imaging in localization of prostate cancer at 3 tesla. Proceedings of the 92nd Annual Meeting of RSNA, Chicago, November 26-December 1, 2006.
80. Harisinghani M., Barentsz J., Hahn P., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348 25 (2003) 2491-2499 Erratum in: N Engl J Med 2003 Sep 4;349(10):1010
81. *-weighted MR imaging at 1.5 and 3T: early experience. Radiology 239 (2006) 481-487